<h1>Medplus Health Services Reports Suspension of Drug Licenses for Subsidiary Stores</h1>
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services Limited, has faced multiple instances of drug license suspension orders for its stores across Karnataka. These actions relate to violations committed under Rule 65 of the Drugs and Cosmetics Act, 1940 and associated Rules, 1945.
The incidents resulted in various suspensions across three different locations within Karnataka, with a collective potential revenue loss noted by the company. The orders were received on July 21, 2026.
Details of the license suspension actions are provided below:
| Authority Name | Location/Circle | Suspension Duration | Potential Revenue Loss |
|---|---|---|---|
| Assistant Director, Drugs Control Administration | New Ksrtc Layout Athani Road, Karnataka | Two days | Rs 0.49 lacs |
| Assistant Director, Drugs Control Administration | Adarsha Nagar Vijayapura, Karnataka | One day | Rs 0.12 lacs |
| Assistant Director, Drugs Control Administration | Chinthamani Bangalore Road, Karnataka | Two days | Rs 0.42 lacs |
The suspensions involved three separate instances: two orders related to stores in the Vijayapura Circle and one order from the Chikkaballapura Circle.
Collectively, these operational incidents carry a potential revenue impact across all listed events.
MEDPLUS Stock Price Movement
Medplus Health Services Limited shares shed value, slipping down 10.40% on Wednesday to settle at ₹691.95. The decline saw the stock reach its 52-week low, with a total traded volume of 2.43 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.